Clinical Trials Browser

Phase EARLY_PHASE1 × Head and Neck Neoplasms × Ketamine × Clear all

NCT02442739 2018-11-06

Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers

Phase EARLY_PHASE1 Withdrawn

GastrointestinalHead & Neck

Depression, Head and Neck Neoplasms, Pancreatic Neoplasms